AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 150 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,650,000 | +517.4% | 228,100 | +189.8% | 0.01% | +400.0% |
| Q3 2019 | $2,211,000 | -1.4% | 78,700 | +5.5% | 0.00% | +100.0% |
| Q2 2018 | $2,242,000 | 0.0% | 74,600 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $2,242,000 | +34.1% | 74,600 | +39.4% | 0.00% | 0.0% |
| Q4 2017 | $1,672,000 | – | 53,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,806,832 | $34,582,764,000 | 27.20% |
| Casdin Capital, LLC | 400,000 | $7,652,000 | 2.83% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,729,268 | $33,081,000 | 1.76% |
| Redmile Group, LLC | 1,459,616 | $27,922,000 | 1.70% |
| Opaleye Management Inc. | 150,000 | $2,869,000 | 1.20% |
| Cormorant Asset Management, LP | 323,545 | $6,189,000 | 1.03% |
| Orbimed Advisors | 4,801,638 | $91,855,000 | 0.96% |
| Perceptive Advisors | 707,500 | $13,534,000 | 0.68% |
| Rock Springs Capital Management LP | 595,200 | $11,386,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $2,870,000 | 0.49% |